“…They described 20 patients with Chiari type 1 malformation and GHD, where 14 patients received GH replacement therapy and six did not. They described that none of the patients with Chiari type 1 malformation and GHD, with or without GH replacement therapy regardless of the change in Chiari type 1 malformation measurement, developed symptoms or syringomyelia, or required surgical intervention (14). Although a subsequent additional report corrected the requirement of decompression surgery in one patient, they concluded, as previously, that the presence of a Chiari type 1 malformation should not prevent initiation of GH therapy (15).…”